| ￥1200 | |
| A03944 | |
|
|
|
|
|
|
|
|
|
| Specificity | This product is specific to GOT1 |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human GOT1 |
| Species Reactivity | Human; Mouse; Rat |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||||
|
|||||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
| Target Background | Biosynthesis of L-glutamate from L-aspartate or L-cysteine. Important regulator of levels of glutamate, the major excitatory neurotransmitter of the vertebrate central nervous system. Acts as a scavenger of glutamate in brain neuroprotection. The aspartate aminotransferase activity is involved in hepatic glucose synthesis during development and in adipocyte glyceroneogenesis. |
| Synonyms | Aspartate aminotransferase 1; ASTQTL1; cAspAT; cCAT; GIG18; Glutamate oxaloacetate transaminase 1; GOT1; Growth inhibiting protein 18; SGOT; Transaminase A; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
